| SCHEDULE OF WARRANT ACTIVITY |
The
following table summarizes warrant activity for the nine months ended March 31, 2025:
SUMMARY OF WARRANT ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average |
|
| |
|
Shares |
|
|
Price Per Share |
|
| Outstanding at June 30, 2024 |
|
|
250 |
|
|
$ |
74,400 |
|
| Granted |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Cancelled * |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at March 31, 2025 |
|
|
250 |
* |
|
$ |
0.01 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at March 31, 2025 |
|
|
250 |
|
|
$ |
0.01 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
1.26 |
|
|
|
|
|
Aggregate intrinsic value
|
|
$ |
- |
|
|
|
|
|
| * |
|
On
March 3, 2025, the Company cancelled all the existing warrants (0.0002 Series A warrants,
0.0003 Series B warrants, and 0.0008 Series C warrants) held by an investor pursuant to a
Warrant Exchange Agreement (see above). |
|
The
following table summarizes common stock warrant activity for the years ended June 30, 2024 and 2023:
SCHEDULE OF WARRANT ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average |
|
| |
|
Warrants |
|
|
Price
Per Share |
|
| Outstanding at June 30, 2022 |
|
|
0.002 |
|
|
$ |
12,016,200,000 |
|
| Issued |
|
|
0.06 |
|
|
|
600,000 |
|
| Exercised |
|
|
(0.0002 |
) |
|
|
3,124,860,000 |
|
| Forfeited |
|
|
(0.00002 |
) |
|
|
120,000,000,000 |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2023 |
|
|
0.06 |
|
|
$ |
326,400,000 |
|
| Issued |
|
|
250 |
|
|
|
74,400 |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Forfeited |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2024 |
|
|
250 |
* |
|
$ |
74,400 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at June 30, 2024 |
|
|
250 |
|
|
$ |
74,400 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
2.01 |
|
|
|
|
|
| Aggregate intrinsic value |
|
$ |
- |
|
|
|
|
|
| * |
The
total warrants of 250 above which are exercisable into common stock consisted of the following: |
|
| SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY |
|
A
summary of the Company’s stock option activity during the years ended June 30, 2024 and 2023 is presented below:
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY
| |
|
|
|
|
Weighted |
|
| |
|
Number of |
|
|
Average |
|
|
|
Options |
|
|
Price
Per Share |
|
| Outstanding at June 30, 2022 |
|
|
0.000001 |
|
|
$ |
271,980,000,000 |
|
| Issued |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2023 |
|
|
0.000001 |
|
|
$ |
271,980,000,000 |
|
| Issued |
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
| Expired |
|
|
- |
|
|
|
- |
|
| Outstanding at June 30, 2024 |
|
|
0.000001 |
|
|
$ |
271,980,000,000 |
|
| |
|
|
|
|
|
|
|
|
| Exercisable at June 30, 2024 |
|
|
0.000001 |
|
|
$ |
271,980,000,000 |
|
| Outstanding and Exercisable: |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Weighted average remaining contractual term |
|
|
4.87 |
|
|
|
|
|
| Weighted average fair value of options granted
during the period |
|
$ |
- |
|
|
|
|
|
| Aggregate intrinsic value |
|
$ |
- |
|
|
|
|
|
|